Hull RD (2008). "Treatment of pulmonary embolism: The use of low-molecular-weight heparin in the inpatient and outpatient settings". Thrombosis and Haemostasis. ج. 99 ع. 3: 502–510. DOI:10.1160/TH07-08-0500. PMID:18327398.
Snow V، Qaseem A، Barry P، Hornbake ER، Rodnick JE، Tobolic T، Ireland B، Segal JB، Bass EB، Weiss KB، Green L، Owens DK (فبراير 2007). "Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians". Annals of Internal Medicine. ج. 146 ع. 3: 204–10. DOI:10.7326/0003-4819-146-3-200702060-00149. PMID:17261857.
Montalescot G، Ellis SG، de Belder MA، Janssens L، Katz O، Pluta W، Ecollan P، Tendera M، van Boven AJ، Widimsky P، Andersen HR، Betriu A، Armstrong P، Brodie BR، Herrmann HC، Neumann FJ، Effron MB، Lu J، Barnathan ES، Topol EJ (فبراير 2010). "Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)". JACC. Cardiovascular Interventions. ج. 3 ع. 2: 203–12. DOI:10.1016/j.jcin.2009.11.012. PMID:20170878.
Dumaine R، Borentain M، Bertel O، Bode C، Gallo R، White HD، Collet JP، Steinhubl SR، Montalescot G (ديسمبر 2007). "Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials". Archives of Internal Medicine. ج. 167 ع. 22: 2423–30. DOI:10.1001/archinte.167.22.2423. PMID:18071163.
Nishioka J، Goodin S (2007). "Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival". Journal of Oncology Pharmacy Practice. ج. 13 ع. 2: 85–97. DOI:10.1177/1078155207079169. PMID:17873108.
Lee AY، Levine MN، Baker RI، Bowden C، Kakkar AK، Prins M، Rickles FR، Julian JA، Haley S، Kovacs MJ، Gent M (يوليو 2003). "Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer". The New England Journal of Medicine. ج. 349 ع. 2: 146–53. DOI:10.1056/NEJMoa025313. PMID:12853587.
Hetzel، Gerd R.؛ Sucker، Christoph (2005). "The heparins: All a nephrologist should know". Nephrology Dialysis Transplantation. ج. 20 ع. 10: 2036–2042. DOI:10.1093/ndt/gfi004. PMID:16030035.
Hull RD (2008). "Treatment of pulmonary embolism: The use of low-molecular-weight heparin in the inpatient and outpatient settings". Thrombosis and Haemostasis. ج. 99 ع. 3: 502–510. DOI:10.1160/TH07-08-0500. PMID:18327398.
Snow V، Qaseem A، Barry P، Hornbake ER، Rodnick JE، Tobolic T، Ireland B، Segal JB، Bass EB، Weiss KB، Green L، Owens DK (فبراير 2007). "Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians". Annals of Internal Medicine. ج. 146 ع. 3: 204–10. DOI:10.7326/0003-4819-146-3-200702060-00149. PMID:17261857.
Montalescot G، Ellis SG، de Belder MA، Janssens L، Katz O، Pluta W، Ecollan P، Tendera M، van Boven AJ، Widimsky P، Andersen HR، Betriu A، Armstrong P، Brodie BR، Herrmann HC، Neumann FJ، Effron MB، Lu J، Barnathan ES، Topol EJ (فبراير 2010). "Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)". JACC. Cardiovascular Interventions. ج. 3 ع. 2: 203–12. DOI:10.1016/j.jcin.2009.11.012. PMID:20170878.
Dumaine R، Borentain M، Bertel O، Bode C، Gallo R، White HD، Collet JP، Steinhubl SR، Montalescot G (ديسمبر 2007). "Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials". Archives of Internal Medicine. ج. 167 ع. 22: 2423–30. DOI:10.1001/archinte.167.22.2423. PMID:18071163.
Nishioka J، Goodin S (2007). "Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival". Journal of Oncology Pharmacy Practice. ج. 13 ع. 2: 85–97. DOI:10.1177/1078155207079169. PMID:17873108.
Lee AY، Levine MN، Baker RI، Bowden C، Kakkar AK، Prins M، Rickles FR، Julian JA، Haley S، Kovacs MJ، Gent M (يوليو 2003). "Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer". The New England Journal of Medicine. ج. 349 ع. 2: 146–53. DOI:10.1056/NEJMoa025313. PMID:12853587.
Nicolaides AN (يونيو 2006). "Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence)". International Angiology : A Journal of the International Union of Angiology. ج. 25 ع. 2: 101–61. PMID:16763532.
Hetzel، Gerd R.؛ Sucker، Christoph (2005). "The heparins: All a nephrologist should know". Nephrology Dialysis Transplantation. ج. 20 ع. 10: 2036–2042. DOI:10.1093/ndt/gfi004. PMID:16030035.